Navigation Links
Frost & Sullivan Honors Clinical Ink for Developing an eSource Platform that Streamlines Clinical Development
Date:9/3/2014

portunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"


SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors
2. Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan
3. Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market
4. Frost & Sullivan Applauds Volpara Solutions Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer
5. Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe
6. Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
7. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
8. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
9. Frost & Sullivan Applauds F Cubed for its Game-Changing MRSA Screener, the NESDEP IU
10. Frost & Sullivan Honors Mobius Imaging for Developing a Mobile 32-Slice CT Scanner, the Airo Mobile Intraoperative CT
11. Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015 Today, the National ... ® ) issued a report urging greater accountability ... is taken against websites illegally selling medications online. ... Outlet Identification Program Progress Report for State and ... thousands of websites illegally distribute medications and avoid ...
(Date:7/31/2015)...  Boston Children,s Hospital physicians report the first ... their anatomy before undergoing high-risk brain procedures. The ... the brain,s blood vessels) that posed special treatment ... Journal of Neurosurgery: Pediatrics , the physicians ... resins to create custom, high-fidelity models of the ...
(Date:7/31/2015)... Quietly, sedately, Morocco,s pharmaceutical sector is shining. ... is strong, with a well-developed base of local producers ... One place where the quality of Moroccan pharma ... quietly become the second largest African exporter of drugs ... Moroccan pharma companies have been making inroads as exporters ...
Breaking Medicine Technology:NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 33D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3
... KENILWORTH, N.J., Oct. 12 Schering-Plough Corporation (NYSE: SGP ... for the 2009 third quarter on Thursday, Oct. 22, 2009. ... day, Schering-Plough will conduct a conference call to review results ... and CEO, and other members of management will host the ...
... today announced that the InterPlate® C-Ti has been cleared for ... in 2007, the C-Ti was the first system cleared by ... recent announcement, the C-Ti has now become the first interbody ... as well. , RSB Spine Chief Executive Officer John A. ...
Cached Medicine Technology:Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings 2
(Date:8/1/2015)... ... , ... Have you ever wondered what “Karma” really means? Does it even exist? Can I ... Vedic tradition, which gave birth to Hinduism, is one of the most ancient spiritual and ... tradition. According to the wisdom of this heritage, Karma is a very real and powerful ...
(Date:8/1/2015)... ... August 01, 2015 , ... ... L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & Wellness (“Premier”) — ... portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy & Wellness ...
(Date:8/1/2015)... ... 01, 2015 , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut ... Trail by stepping off Springer Mountain and heading north. Since that day, Phil has ... Connecticut and was greeted by friends and family. He visited CCAR and left an ...
(Date:7/31/2015)... Santa Clara, CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 ... The National Football League’s biggest day each year is the Super Bowl. In the ... buildup that takes place from the host venue. The 2016 Super Bowl game will mark ...
(Date:7/31/2015)... ... 31, 2015 , ... The 2nd annual Ride to Fight On will start ... 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits the ... West Clinic and The University of Tennessee Health Science Center. A health and wellness ...
Breaking Medicine News(10 mins):Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... technology delivers new levels of analysis of heart,s ... NewCardio, Inc., (OTC Bulletin Board: NWCI) a ... members of the Company,s medical and technology teams ... from analytical and clinical applications of its proprietary ...
... of Upcoming ASCO PresentationBELLEVUE, Wash., May 18 Light ... preclinical study has yielded evidence that the company,s novel ... and prevent metastases. Results of the study will be ... Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, ...
... First and Only Long-Acting Antipsychotic Therapy Available for ... Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. today announced the ... the Supplemental New Drug Applications (sNDAs) for the ... as both monotherapy and adjunctive therapy to lithium ...
... information technology and innovative partnerships help promote prevention ... 18 Target Corporation (NYSE: TGT ... wellness resources designed to support the company,s increased ... part of the company,s commitment to employees (called ...
... May 18 WaferGen Biosystems, Inc. (OTC Bulletin ... analysis systems, today announced two key appointments, naming ... of directors and Lincoln J. McBride, Ph.D., as ... scientific advisory board. With extensive life science ...
... Payments from New Galderma Collaboration Resulted in Positive ... NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ... products for the treatment and prevention of a ... today its financial results and operational highlights for ...
Cached Medicine News:Health News:NewCardio Medical and Technology Team Presents Two Abstracts at Heart Rhythm Society Conference 2Health News:NewCardio Medical and Technology Team Presents Two Abstracts at Heart Rhythm Society Conference 3Health News:NewCardio Medical and Technology Team Presents Two Abstracts at Heart Rhythm Society Conference 4Health News:NewCardio Medical and Technology Team Presents Two Abstracts at Heart Rhythm Society Conference 5Health News:Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer 2Health News:Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer 3Health News:Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer 4Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 2Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 3Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 4Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 5Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 6Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 7Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 8Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 9Health News:FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder 10Health News:Target Corporation Makes Getting and Staying Healthy Easier 2Health News:Target Corporation Makes Getting and Staying Healthy Easier 3Health News:Target Corporation Makes Getting and Staying Healthy Easier 4Health News:Target Corporation Makes Getting and Staying Healthy Easier 5Health News:Target Corporation Makes Getting and Staying Healthy Easier 6Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 2Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 3Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 4Health News:WaferGen Appoints Seasoned Industry Executives to Board of Directors and Scientific Advisory Board 5Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 2Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 3Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 4Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 5Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 6Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 7Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 8Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 9
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (hCG) in urine specimens...
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: